OpenVSafe by OpenVAERS
Search V-safe

5RW-29764-52693

3 vaccinations 2 coded responses 15 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
752 / TX
Registered
2022-06-22
Relationship
Child or adolescent in my care
Guardian
27M-24350-03160
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-12-20
    Dose 1 — Pfizer-BioNTech
  2. 2022-01-10
    Dose 2 — Pfizer-BioNTech
  3. 2022-06-22
    Registered in v-safe
  4. 2022-07-11
  5. 2022-07-22
    Dose 3 — Moderna
  6. 2022-07-22
    Health check-in — day 0, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  7. 2022-07-23
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  8. 2022-07-24
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  9. 2022-07-26
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2022-07-27
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2022-07-28
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  12. 2022-07-29
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  13. 2022-08-05
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-08-12
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  15. 2022-08-19
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-08-26
    Survey response — day 35, dose 3, dependent
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-09-02
    Health check-in — day 42, dose 3, dependent
    Feeling: Fair
    Adult check-in
  18. 2022-10-23
  19. 2023-01-20
    Survey response — 6 months, dose 3, dependent
    MedDRA: COVID-19, Gastrointestinal viral infection, General physical health deterioration, Nasopharyngitis, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-12-20Pfizer-BioNTech No
22022-01-10Pfizer-BioNTech No
32022-07-22Moderna No

Free text

Release 12 — day 35, dose 3, dependent

2022-08-26

Symptoms: Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDGastrointestinal viral infection · · ✓
SDGeneral physical health deterioration · · ✓
SDNasopharyngitis · · ✓
SDOropharyngeal pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release